244 results
Page 7 of 13
8-K
3tp8rxgexgj
7 Mar 12
Discovery Labs Announces FDA Approval of SURFAXIN® (lucinactant) for Prevention of Respiratory Distress Syndrome
12:00am
8-K
EX-99.1
rrxjxaucxzx qe3
8 Feb 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
8lssjw1wx69dd
2 Feb 12
Other Events
12:00am
424B5
3tl 1iqc5gpsl826
15 Dec 11
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
lhxqk80f9237sbqh17pv
28 Sep 11
Other Events
12:00am
8-K
qag8klxy 2nhz12uwnb
29 Jul 11
Other Events
12:00am
8-K
EX-99.1
fdn7flcwe1ktz9 55c
29 Jul 11
Other Events
12:00am
8-K
EX-99.1
mzcz4dic ey
1 Jun 11
Other Events
12:00am
424B5
r7xw0jvfx5wth
17 Feb 11
Prospectus supplement for primary offering
12:00am
424B5
n41oa4 mtnmtbqdfs
15 Feb 11
Prospectus supplement for primary offering
12:00am
CORRESP
zhh5ofc 85k
10 Nov 10
Correspondence with SEC
12:00am
CORRESP
z56p ih9e
8 Nov 10
Correspondence with SEC
12:00am